132 related articles for article (PubMed ID: 25398438)
1. Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis.
Fan X; He C; Jing W; Zhou X; Chen R; Cao L; Zhu M; Jia R; Wang H; Guo Y; Zhao J
Cancer Res; 2015 Jan; 75(1):86-97. PubMed ID: 25398438
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to toll-like receptor agonists.
Zhao W; Wang L; Zhang L; Yuan C; Kuo PC; Gao C
J Biol Chem; 2010 Jul; 285(27):20452-61. PubMed ID: 20427276
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages.
Shimizu S; Okuda N; Kato N; Rittling SR; Okawa A; Shinomiya K; Muneta T; Denhardt DT; Noda M; Tsuji K; Asou Y
Arthritis Rheum; 2010 May; 62(5):1329-37. PubMed ID: 20155835
[TBL] [Abstract][Full Text] [Related]
4. Intracellular osteopontin negatively regulates toll-like receptor 4-mediated inflammatory response via regulating GSK3β and 4EBP1 phosphorylation.
Yang H; Ye X; Zhang X; Li X; Fu Q; Tang Z
Cytokine; 2018 Aug; 108():89-95. PubMed ID: 29587154
[TBL] [Abstract][Full Text] [Related]
5. Intracellular osteopontin (iOPN) and immunity.
Inoue M; Shinohara ML
Immunol Res; 2011 Apr; 49(1-3):160-72. PubMed ID: 21136203
[TBL] [Abstract][Full Text] [Related]
6. Dual regulation of osteopontin production by TLR stimulation in dendritic cells.
Salvi V; Scutera S; Rossi S; Zucca M; Alessandria M; Greco D; Bosisio D; Sozzani S; Musso T
J Leukoc Biol; 2013 Jul; 94(1):147-58. PubMed ID: 23610145
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin is involved in estrogen-mediated protection against diethylnitrosamine-induced liver injury in mice.
He C; Fan X; Chen R; Liang B; Cao L; Guo Y; Zhao J
Food Chem Toxicol; 2012 Aug; 50(8):2878-85. PubMed ID: 22609492
[TBL] [Abstract][Full Text] [Related]
8. Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.
Uhlmann ME; Georges RB; Boleij A; Eyol E; Kubarenko A; Adwan H; Berger MR
Cancer Gene Ther; 2011 Nov; 18(11):795-805. PubMed ID: 21852811
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: critical role of intracellular osteopontin in antifungal innate immune responses.
Inoue M; Moriwaki Y; Arikawa T; Chen YH; Oh YJ; Oliver T; Shinohara ML
J Immunol; 2011 Jan; 186(1):19-23. PubMed ID: 21135164
[TBL] [Abstract][Full Text] [Related]
10. Role of Hepatocyte-Derived Osteopontin in Liver Carcinogenesis.
Desert R; Ge X; Song Z; Han H; Lantvit D; Chen W; Das S; Athavale D; Abraham-Enachescu I; Blajszczak C; Chen Y; Musso O; Guzman G; Hoshida Y; Nieto N
Hepatol Commun; 2022 Apr; 6(4):692-709. PubMed ID: 34730871
[TBL] [Abstract][Full Text] [Related]
11. Role of Osteopontin in Liver Diseases.
Wen Y; Jeong S; Xia Q; Kong X
Int J Biol Sci; 2016; 12(9):1121-8. PubMed ID: 27570486
[TBL] [Abstract][Full Text] [Related]
12. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
13. OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages.
Many GM; Yokosaki Y; Uaesoontrachoon K; Nghiem PP; Bello L; Dadgar S; Yin Y; Damsker JM; Cohen HB; Kornegay JN; Bamman MM; Mosser DM; Nagaraju K; Hoffman EP
Exp Physiol; 2016 Oct; 101(10):1285-1300. PubMed ID: 27452303
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin as a therapeutic target for cancer.
Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
[TBL] [Abstract][Full Text] [Related]
15. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
Bourassa B; Monaghan S; Rittling SR
Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
[TBL] [Abstract][Full Text] [Related]
16. Regulatory role of DC-derived osteopontin in systemic allergen sensitization.
Kurokawa M; Konno S; Takahashi A; Plunkett B; Rittling SR; Matsui Y; Kon S; Morimoto J; Uede T; Matsukura S; Kokubu F; Adachi M; Nishimura M; Huang SK
Eur J Immunol; 2009 Dec; 39(12):3323-30. PubMed ID: 19830723
[TBL] [Abstract][Full Text] [Related]
17. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin.
Kon S; Ikesue M; Kimura C; Aoki M; Nakayama Y; Saito Y; Kurotaki D; Diao H; Matsui Y; Segawa T; Maeda M; Kojima T; Uede T
J Exp Med; 2008 Jan; 205(1):25-33. PubMed ID: 18158320
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity.
Bertola A; Deveaux V; Bonnafous S; Rousseau D; Anty R; Wakkach A; Dahman M; Tordjman J; Clément K; McQuaid SE; Frayn KN; Huet PM; Gugenheim J; Lotersztajn S; Le Marchand-Brustel Y; Tran A; Gual P
Diabetes; 2009 Jan; 58(1):125-33. PubMed ID: 18952835
[TBL] [Abstract][Full Text] [Related]
20. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice.
Lee SH; Park JW; Woo SH; Go DM; Kwon HJ; Jang JJ; Kim DY
Oncotarget; 2016 Dec; 7(52):87219-87231. PubMed ID: 27888617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
